Form 8-K - Current report:
SEC Accession No. 0001558370-22-014906
Filing Date
2022-10-07
Accepted
2022-10-07 16:30:17
Documents
13
Period of Report
2022-10-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20221004x8k.htm   iXBRL 8-K 39970
2 EX-99.1 agrx-20221004xex99d1.htm EX-99.1 23083
  Complete submission text file 0001558370-22-014906.txt   191024

Data Files

Seq Description Document Type Size
3 EX-101.SCH agrx-20221004.xsd EX-101.SCH 3175
4 EX-101.LAB agrx-20221004_lab.xml EX-101.LAB 15926
5 EX-101.PRE agrx-20221004_pre.xml EX-101.PRE 10130
7 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20221004x8k_htm.xml XML 4858
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 221301076
SIC: 2834 Pharmaceutical Preparations